REG - IP Group PLC - Portfolio company Hinge Health files for IPO

IPAnnouncement

11/03/2025 08:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250311:nRSK1646Aa&default-theme=true

RNS Number : 1646A  IP Group PLC  11 March 2025

 FOR RELEASE ON  11 March 2025

 

IP Group plc - Hinge Health files for IPO

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which invests in
breakthrough science and innovation companies with the potential to create a
better future for all, is pleased to note that portfolio company Hinge Health
Inc ("Hinge Health" or "the Company") has filed its IPO prospectus with the US
Securities and Exchange Commission.

As the founding investor in Hinge Health, IP Group has a 1.8% holding in the
Company, valued by IP Group at £34.2m as at 30 June 2024.

Headquartered in San Francisco, California, Hinge Health leverages software,
including AI, to largely automate care for joint and muscle health. The
company has designed its platform to address a broad spectrum of MSK care -
from acute injury, to chronic pain, to post-surgical rehabilitation - and the
platform can help to ease members' pain, improve their function, and reduce
their need for surgeries, all while driving health equity by allowing members
to engage in their exercise therapy sessions from anywhere.

Hinge Health noted that the number of shares to be offered and the price range
for the proposed offering have not yet been determined. The offering is
subject to market conditions, and there can be no assurance as to whether or
when the offering may be completed, or as to the actual size or terms of the
offering.

Hinge Health intends to list its Class A common stock on the New York Stock
Exchange under the ticker symbol "HNGE."

Morgan Stanley, Barclays and BofA Securities are acting as lead book-running
managers for the proposed offering. Evercore ISI, RBC Capital Markets, Truist
Securities, Stifel, William Blair, Piper Sandler, Canaccord Genuity, KeyBanc
Capital Markets, Needham & Company, Raymond James, and KKR Capital Markets
LLC are also acting as book-running managers.

For more information, please contact:

 

 IP Group plc                       www.ipgroupplc.com
 Liz Vaughan-Adams, Communications  +44 (0) 20 7444 0062/+44 (0) 7967 312125
 Portland
 Alex Donaldson                     +44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. As the most
active UK based, early stage science investor, we develop and support some of
the world's most exciting businesses in deeptech, life sciences and cleantech
(led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund
manager, we also back world-changing innovation emerging in leading
universities and research institutions. Our specialist investment team
combines sector expertise with an international approach. Together we have a
strong track record of success, having backed high-profile companies including
Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxa. IP
Group is listed on the Main Market of the London Stock Exchange under the code
IPO. For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCGRGDXUSBDGUB